There is no Press for this Ticker
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, pain. The company's lead product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

Related Companies

TickerCompanyChg %Mkt Cap
IPCIFIntelliPharmaCeutics Intl-1.81%6.8M

IntelliPharmaCeutics Intl Company Questions & Answers

Q

How do I buy IntelliPharmaCeutics Intl (IPCIF) stock?

A

You can purchase shares of IntelliPharmaCeutics Intl (OTC: IPCIF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are IntelliPharmaCeutics Intl's (IPCIF) main competitors?

A

There are no as such competitors for IntelliPharmaCeutics Intl.

Q

What is the target price for IntelliPharmaCeutics Intl?

A

There is no analysis for IntelliPharmaCeutics Intl

Q

How much is IntelliPharmaCeutics Intl (IPCIF) stock ?

A

The stock price for IntelliPharmaCeutics Intl (OTC: IPCIF) is $0.2062 last updated Mon May 10 2021 18:31:21 GMT+0000 (Coordinated Universal Time).

Q

When is the next IntelliPharmaCeutics Intl (IPCIF) dividend?

A

There are no upcoming dividends for IntelliPharmaCeutics Intl.

Q

When is IntelliPharmaCeutics Intl (OTC:IPCIF) reporting earnings?

A

There are no earnings for IntelliPharmaCeutics Intl

Q

When is the upcoming split for IPCIF?

A

There is no upcoming split for IntelliPharmaCeutics Intl.